FRANKLIN COVEY CO. Accrued Liabilities, Current
FRANKLIN COVEY CO. (FC) had Accrued Liabilities, Current of $20.73 million as of 2026-05-31, per its 10-Q filed 2026-07-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-07-07
- 2026-05-31: Accrued Liabilities, Current $20.73M.
- 2026-02-28: Accrued Liabilities, Current $21.84M.
- 2025-11-30: Accrued Liabilities, Current $21.39M.
- 2025-08-31: Accrued Liabilities, Current $24.83M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-05-31 | $20.73M 10-Q · filed 2026-07-07 | |
| 2026-02-28 | $21.84M 10-Q · filed 2026-04-08 | |
| 2025-11-30 | $21.39M 10-Q · filed 2026-01-09 | |
| 2025-08-31 | $24.83M 10-Q · filed 2026-07-07 | |
| 2025-05-31 | $21.49M 10-Q · filed 2025-07-08 | |
| 2025-02-28 | $16.85M 10-Q · filed 2025-04-08 | |
| 2024-11-30 | $23.89M 10-Q · filed 2025-01-10 | |
| 2024-08-31 | $32.45M 10-K · filed 2025-11-12 | |
| 2024-05-31 | $22.21M 10-Q · filed 2024-07-08 | |
| 2024-02-29 | $19.30M 10-Q · filed 2024-04-05 | |
| 2023-11-30 | $21.30M 10-Q · filed 2024-01-09 | |
| 2023-08-31 | $28.25M 10-K · filed 2024-11-12 | |
| 2023-05-31 | $23.94M 10-Q · filed 2023-07-07 | |
| 2023-02-28 | $18.65M 10-Q · filed 2023-04-05 | |
| 2022-11-30 | $23.38M 10-Q · filed 2023-01-09 | |
| 2022-08-31 | $34.20M 10-K · filed 2023-11-13 | |
| 2022-05-31 | $28.57M 10-Q · filed 2022-07-07 | |
| 2022-02-28 | $23.30M 10-Q · filed 2022-04-06 | |
| 2021-11-30 | $26.11M 10-Q · filed 2022-01-07 | |
| 2021-08-31 | $34.98M 10-K · filed 2022-11-14 | |
| 2021-05-31 | $28.01M 10-Q · filed 2021-07-08 | |
| 2021-02-28 | $22.84M 10-Q · filed 2021-04-08 | |
| 2020-11-30 | $21.90M 10-Q · filed 2021-01-08 | |
| 2020-08-31 | $22.63M 10-K · filed 2021-11-12 | |
| 2020-05-31 | $18.21M 10-Q · filed 2020-07-10 | |
| 2020-02-29 | $18.72M 10-Q · filed 2020-04-09 | |
| 2019-11-30 | $16.98M 10-Q · filed 2020-01-09 | |
| 2019-08-31 | $23.55M 10-K · filed 2020-11-16 | |
| 2019-05-31 | $20.50M 10-Q · filed 2019-07-09 | |
| 2019-02-28 | $16.07M 10-Q · filed 2019-04-09 | |
| 2018-11-30 | $16.95M 10-Q · filed 2019-01-09 | |
| 2018-08-31 | $20.76M 10-K · filed 2019-11-14 | |
| 2018-05-31 | $17.13M 10-Q · filed 2018-07-10 | |
| 2018-02-28 | $18.99M 10-Q · filed 2018-04-09 | |
| 2017-11-30 | $15.78M 10-Q · filed 2018-01-09 | |
| 2017-08-31 | $22.62M 10-K · filed 2018-11-14 | |
| 2017-05-31 | $16.16M 10-Q · filed 2017-07-10 | |
| 2017-02-28 | $14.29M 10-Q · filed 2017-04-07 | |
| 2016-11-26 | $13.52M 10-Q · filed 2017-01-05 | |
| 2016-08-31 | $17.42M 10-K · filed 2017-11-14 | $17.42M 10-K · filed 2016-11-14 |
| 2016-05-28 | $24.09M 10-Q · filed 2016-07-07 | |
| 2016-02-27 | $22.29M 10-Q · filed 2016-04-07 | |
| 2015-11-28 | $21.39M 10-Q · filed 2016-01-08 | |
| 2015-08-31 | $16.88M 10-K · filed 2016-11-14 | $29.63M 10-K · filed 2015-11-13 |
| 2015-05-30 | $20.22M 10-Q · filed 2015-07-09 | |
| 2015-02-28 | $19.52M 10-Q · filed 2015-04-09 | |
| 2014-11-29 | $20.02M 10-Q · filed 2015-01-08 | |
| 2014-08-31 | $29.59M 10-K · filed 2015-11-13 | |
| 2014-05-31 | $20.82M 10-Q · filed 2014-07-10 | |
| 2014-03-01 | $18.60M 10-Q · filed 2014-04-10 | |
| 2013-11-30 | $19.49M 10-Q · filed 2014-01-09 | |
| 2013-08-31 | $31.14M 10-K · filed 2014-11-14 | |
| 2013-06-01 | $22.80M 10-Q · filed 2013-07-11 | |
| 2013-03-02 | $17.98M 10-Q · filed 2013-04-11 | |
| 2012-12-01 | $17.70M 10-Q · filed 2013-01-10 | |
| 2012-08-31 | $24.53M 10-K · filed 2013-11-14 | |
| 2012-05-26 | $18.90M 10-Q · filed 2012-07-03 | |
| 2012-02-25 | $19.13M 10-Q · filed 2012-04-04 | |
| 2011-11-26 | $17.44M 10-Q/A · filed 2012-01-26 | |
| 2011-08-31 | $22.81M 10-K · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |